HCW Biologics reduces shareholder quorum requirement to 33-1/3%

HCW Biologics Inc.

Board approved amendment lowering quorum from majority to 33-1/3% of voting power.
Amendment effective April 28, 2026.
Quorum now defined as holders of 33-1/3% voting power present in person or by proxy.
Prior quorum required holders of a majority of outstanding voting power.

item 5.03 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Governance Changes SEC 8-K Item 5.03/5.05/5.06 confidence 0.9

HCW Biologics Inc.: Lowered quorum requirement from majority to 33⅓% of voting power (effective 2026-04-28).

Change: bylaw amendment
Effective: 2026-04-28

Exact text from the filing

The amendment, which is effective from and after April 28, 2026, lowers the quorum requirement contained in Section 1.5 of the Bylaws to provide that holders of thirty-three and one-third percent (33 1/3%) of the voting power, which includes the voting power that is present in person or by proxy, regardless of whether the proxy has authority to vote on any matter, constitutes a quorum for the transaction of business (the “ Amendment ”).

View on SEC.gov

89 governance changes filed in the last 30 days. Browse all governance changes →

HCW Biologics Inc. filing history →

Source: SEC EDGAR

accession 0001493152-26-017099

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.